Andrew R. Allen
2015
In 2015, Andrew R. Allen earned a total compensation of $5M as Former EVP of Clinical and Pre-Clinical Development and Chief Medical Officer at Clovis Oncology, a 28% increase compared to previous year.
Compensation breakdown
| Option Awards | $4,644,470 |
|---|---|
| Salary | $324,578 |
| Other | $13,121 |
| Total | $4,982,170 |
Allen received $4.6M in option awards, accounting for 93% of the total pay in 2015.
Allen also received $324.6K in salary and $13.1K in other compensation.
Rankings
In 2015, Andrew R. Allen's compensation ranked 1,602nd out of 13,638 executives tracked by ExecPay. In other words, Allen earned more than 88.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,602 out of 13,638 | 88th |
Division Manufacturing | 578 out of 5,187 | 89th |
Major group Chemicals And Allied Products | 213 out of 1,857 | 89th |
Industry group Drugs | 164 out of 1,531 | 89th |
Industry Pharmaceutical Preparations | 132 out of 1,179 | 89th |
Source: SEC filing on April 27, 2016.
Allen's colleagues
We found five more compensation records of executives who worked with Andrew R. Allen at Clovis Oncology in 2015.
2015
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
2015
Lindsey Rolfe
Clovis Oncology
Chief Medical Officer
2015
Gillian Ivers-Read
Clovis Oncology
EVP of Technical Operations and Chief Regulatory Officer
2015
Erle Mast
Clovis Oncology
Chief Financial Officer
2015
Steven Hoerter
Clovis Oncology